周五盘中，PTC Therapeutics Inc.（股票代码：PTCT）股价大跌6.91%，主要原因是该公司公布的季度业绩远低于市场预期。
根据公司最新发布的财报，截至6月30日的季度，PTC Therapeutics调整后每股亏损83美分，远高于分析师平均预期的21美分亏损。相比之下，去年同期该公司每股收益为1.27美元。此外，公司季度营收为11.8亿美元，同比下降4.2%，也低于分析师预期的1.6825亿美元。
值得注意的是，尽管公司本季度每股收益为10.04美元，但当季仍亏损6485万美元。这一业绩表现显著低于市场预期，导致投资者信心受挫。分析师对公司未来表现的看法也出现分歧，过去30天内有6位分析师下调了对该公司的盈利预测。尽管如此，华尔街分析师对PTC Therapeutics的12个月目标价中位数仍为64.00美元，较当前股价有约21.3%的上涨空间。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.